Browse by Section 100 Item List

HIGHLY SPECIALISED DRUGS PROGRAM (Public Hospital)

For Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Maximum quantities and repeats for Highly Specialised Drugs are listed in the Schedule. Highly Specialised Drugs prescribed through public hospitals, except Complex Authority Required Highly Specialised Drugs, are Authority required (STREAMLINED) PBS Prescriptions. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats. Complex Authority Required Highly Specialised Drugs require written authority applications. Approval of authority prescriptions by Services Australia may be obtained either by posting an Authority Prescription Form to Services Australia, or by using the Services Australia Authority free-call service (1800 888 333). Prescribers must quote the provider number of the hospital when applying.

Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies. A patient will be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the Pharmaceutical Benefits Scheme. Commonwealth subsidy is not available for hospital in-patients.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 12856P RAVULIZUMABravulizumab 1.1 g/11 mL injection, 11 mL vial 1 1 0
MP 12883C RAVULIZUMABravulizumab 1.1 g/11 mL injection, 11 mL vial 1 1 2
MP 12884D RAVULIZUMABravulizumab 300 mg/3 mL injection, 3 mL vial 1 1 2
MP 12898W RAVULIZUMABravulizumab 300 mg/3 mL injection, 3 mL vial 1 1 0
MPNP 12786Y RIBAVIRINribavirin 200 mg tablet, 100 2 200 2
MPNP 9541E RIFABUTINrifabutin 150 mg capsule, 30 4 120 5
MP 11020B RIOCIGUATriociguat 1 mg tablet, 84 1 84 0
MP 11053R RIOCIGUATriociguat 1 mg tablet, 84 1 84 5
MP 10989J RIOCIGUATriociguat 1.5 mg tablet, 42 1 42 0
MP 11047K RIOCIGUATriociguat 1.5 mg tablet, 42 1 42 0
MP 10977R RIOCIGUATriociguat 1.5 mg tablet, 84 1 84 0
MP 11048L RIOCIGUATriociguat 1.5 mg tablet, 84 1 84 5
MP 10984D RIOCIGUATriociguat 2 mg tablet, 42 1 42 0
MP 11038Y RIOCIGUATriociguat 2 mg tablet, 42 1 42 0
MP 11013P RIOCIGUATriociguat 2 mg tablet, 84 1 84 0
MP 11039B RIOCIGUATriociguat 2 mg tablet, 84 1 84 5
MP 11002C RIOCIGUATriociguat 2.5 mg tablet, 42 1 42 0
MP 11057Y RIOCIGUATriociguat 2.5 mg tablet, 42 1 42 0
MP 11019Y RIOCIGUATriociguat 2.5 mg tablet, 84 1 84 0
MP 11024F RIOCIGUATriociguat 2.5 mg tablet, 84 1 84 5
MP 11001B RIOCIGUATriociguat 500 microgram tablet, 42 1 42 0
MP 11040C RIOCIGUATriociguat 500 microgram tablet, 42 1 42 0
MP 10995Q RIOCIGUATriociguat 500 microgram tablet, 84 1 84 0
MP 11059C RIOCIGUATriociguat 500 microgram tablet, 84 1 84 5
MP 10976Q RIOCIGUATriociguat 1 mg tablet, 42 1 42 0
MP 11054T RIOCIGUATriociguat 1 mg tablet, 42 1 42 0
MP 12606L RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 1 1 5
MP 12614X RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 1 1 0
MP 12943F RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 1 1 0
MP 13088W RITUXIMABrituximab 100 mg/10 mL injection, 10 mL vial 6 6 0
MP 13082M RITUXIMABrituximab 100 mg/10 mL injection, 2 x 10 mL vials 3 6 0
MP 13101M RITUXIMABrituximab 500 mg/50 mL injection, 50 mL vial 2 2 1
MP 9696H ROMIPLOSTIMromiplostim 250 microgram injection, 1 vial 1 1 5
MP 9698K ROMIPLOSTIMromiplostim 500 microgram injection, 1 vial 1 1 5
MP 13232K RUXOLITINIBruxolitinib 10 mg tablet, 56 1 56 0
MP 13245D RUXOLITINIBruxolitinib 10 mg tablet, 56 1 56 5
MP 13238R RUXOLITINIBruxolitinib 5 mg tablet, 56 1 56 5
MP 13243B RUXOLITINIBruxolitinib 5 mg tablet, 56 1 56 0